Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/1991
12/12/1991WO1991015512A3 Hiv envelope polypeptides
12/12/1991WO1991014778A3 BACILLUS THURINGIENSIS cryIIIC GENE AND PROTEIN TOXIC TO COLEOPTERAN INSECTS
12/12/1991WO1991008291A3 Latency associated peptide and uses therefor
12/12/1991CA2084062A1 Mammalian adipogenic factors
12/12/1991CA2082529A1 Immunodiagnostic assay for rheumatoid arthritis
12/12/1991CA2064752A1 Antifungal preparations, process for making such preparations, process for obtaining plants with decreased susceptibility to fungi
12/12/1991CA2044201A1 Inactive precursor forms of ribosome inactivating proteins, a process for making and a method of using
12/12/1991CA2042868A1 Bacillus thuringiensis microbes active against nematodes, and genes encoding novel nematode-active toxins cloned from bacillus thuringiensis isolates
12/11/1991EP0460910A2 Tumor cell growth inhibitor
12/11/1991EP0460846A1 Type II interleukin-1 receptors
12/11/1991EP0460753A2 New Antifungal preparations, process for making such preparations, process for obtaining plants with decreased susceptibility to fungi
12/11/1991EP0460716A1 Yeast expression systems with vectors having GAPDH promoters, and synthesis of HBsAg
12/11/1991EP0460709A1 AraB promoters and method of producing polypeptides, including cecropins, by microbiological techniques
12/11/1991EP0460674A2 Recombinant DNA and process for the production of chimaeric antibodies
12/11/1991EP0460607A2 Novel monoclonal antibody to novel antigen associated with human tumors
12/11/1991EP0460426A2 Protein purification method
12/11/1991EP0460217A1 cDNA OF ORSV GENE
12/11/1991EP0460189A1 Production of biologically active platelet-derived growth factor from high expression host cell systems
12/11/1991EP0460177A1 Method for intensive, in vitro culture of babesia divergens strains, method for preparing exoantigens and vaccines containing these antigens
12/11/1991EP0460101A1 Immobilized cytokines
12/11/1991EP0460094A1 Preventing false-positive results in elisa-assay methods
12/11/1991EP0460072A1 Human elastase inhibitor
12/11/1991EP0460064A1 Therapeutic aerosol formulations
12/11/1991EP0460058A1 Use of bactericidal/permeability increasing protein or biologically active analogs thereof for the manufacture of a medicament to treat endotoxin-associated disorders
12/11/1991EP0460052A1 Il-1 biological activity inhibitors
12/11/1991EP0460021A1 Chimeric toxin
12/11/1991EP0235187B1 Polypeptides and antibodies characteristic of the papillomavirus, methods of diagnosis and vaccines in which they are used
12/11/1991CN1056816A Improved vaccine compositions
12/10/1991US5071964 Having phosphatidylinositol lipid anchor; inhibit adhesion of T-cells to other lymphocytes by binding to them
12/10/1991US5071963 Interferon-induced human (2'-5') oligo a synthetase
12/10/1991US5071962 Detection; vaccine against chlamydia infection
12/10/1991US5071961 Adsorption on alpha-hydroxyaminopropyl-modified adsorber, then elution
12/10/1991US5071960 Cleaning compounds; cosmetics, drugs
12/10/1991US5071959 Novel lymphokine for suppressing platelet activation
12/10/1991US5071956 Glycoproteins for treating vision defects, arthritis, cardiovascular disorders, tumors and rheumatic dieseases
12/10/1991US5071955 Octopeptide exhibiting antimypertensive activity
12/10/1991US5071954 Used for immunization of animals and purification of specific antibodies; purity
12/10/1991US5071834 Purified activin B composition
12/10/1991US5071773 Hormone receptor-related bioassays
12/10/1991US5071761 Dna sequence coding for human lymphoblastoid interferons
12/10/1991US5071759 Immunological cross-reactivity; immunoassay; colitis
12/10/1991US5071758 Veterinary medicine
12/10/1991US5071756 Bacterial FC receptors
12/10/1991US5071654 Ion channel properties of delta endotoxins
12/10/1991US5071651 Rotavirus nucleocapsid protein VP6 as a carrier in vaccine compositions
12/09/1991WO1991019011A1 Immunoassays for anti-hiv-1 antibodies
12/09/1991CA2082806A1 Immunoassays for anti-hiv-1 antibodies
12/09/1991CA2043516A1 Recombinant dna and process for the production of chimeric antibodies
12/07/1991WO1991018920A1 Sm-d antigen peptides and their use, in particular, for the diagnosis of systemic lupus erythematosus
12/07/1991WO1991018617A1 Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae
12/07/1991CA2064576A1 Sm-d antigen peptides and their use notably in the diagnostic of systemic lupus erythematosus
12/06/1991WO1991018979A1 Method of isolating restriction fragment deletions in vibrio cholerae, and products thereof
12/06/1991CA2043951A1 Monoclonal antibody to novel antigen associated with human tumors
12/06/1991CA2042448A1 Antimicrobial peptides and plant disease resistance based thereon
12/05/1991WO1991018927A1 Method for preparing interferon alpha-2 crystals
12/05/1991CA2084406A1 Method for preparing interferon alpha-2 crystals
12/04/1991EP0459842A1 Process for the production of retroviral immunogenes and vaccines against retroviral infections, especially HIV, and immunogens and vaccines thereof
12/04/1991EP0459788A2 Modified proteins and methods of producing same
12/04/1991EP0459779A1 Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) GP120 and methods of use
12/04/1991EP0459747A1 Precursor forms of porcine growth hormone releasing factor and related DNA compounds
12/04/1991EP0459630A2 Polypeptides
12/04/1991EP0459624A2 Galactosamine-substituted poly-omega-substituted-L-glutamic and/or-aspartic acid
12/04/1991EP0459577A2 Microbially expressed portions of a monoclonal antibody block rhinovirus attachment to cell receptors
12/04/1991EP0459564A2 Process for reduction of echinocandin type cyclohexapeptide compounds
12/04/1991EP0459533A2 Probe groups for the detection of nucleotide variations and genetic polymorphisms
12/04/1991EP0459532A2 Primers and probes for nucleic acid detection
12/04/1991EP0459465A2 HIV-protease inhibitors and process for their preparation
12/04/1991EP0459387A2 Phencyclidine and phencyclidine metabolites assay, tracers, immunogens, antibodies and reagent kit
12/04/1991EP0459372A2 Hybridoma and production of biologically active substance
12/04/1991EP0458918A1 Method for obtaining a recombinant protein and its utilization in the assay for the african swine pest virus (aspv)
12/04/1991EP0458911A1 ENDOTHELIAL CELL-LEUKOCYTE ADHESION MOLECULES (ELAMs) AND MOLECULES INVOLVED IN LEUKOCYTE ADHESION (MILAs)
12/04/1991EP0458908A1 Animal model for benign prostatic disease
12/04/1991EP0458903A1 Soluble analogs of thrombomodulin
12/04/1991EP0458901A1 Inhibiting transformation of cells having elevated purine metabolic enzyme activity
12/04/1991EP0433312A4 Carrier system and method for enhancement of magnetic resonance imaging
12/04/1991EP0182888B1 Method and reactant for the differential determination of isoenzymes of the alkaline phosphatase and monoclonal antibody therefore
12/04/1991CN1056632A Apparatus preparing concentrate of coagulation factors, such as fibrinogen, from blood sample
12/03/1991US5070188 Acylated epidermal growth factor
12/03/1991US5070186 Improved solubility and absorption
12/03/1991US5070076 Polypeptide mixture; immunostimulant; side effect reduction; n onallergenic
12/03/1991US5070075 Human preproinsulin-like growth factor I
12/03/1991US5070013 Immunochemical assay for human granulocyte-macrophage colony stimulating factor
12/03/1991US5069901 Deactivated antigens
12/03/1991US5069896 Malodor inhibiting skin deodorant composition comprising a monoclonal antibody and method of deodorizing
12/03/1991CA1292841C Peptide derivatives, their production and use
12/03/1991CA1292840C Sequencing of peptides
12/03/1991CA1292839C Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen
12/03/1991CA1292708C Monoclonal antibody against plasminogen-activating factor
12/03/1991CA1292690C Vaccine comprising an immunogenic protein and, as an adjuvant, a substantially non-immunogenic sequentially homologous peptide
12/03/1991CA1292686C Pharmaceutical compositions of recombinant interleukin-2 and formulation process
12/02/1991WO1991019000A1 A MONOCLONAL ANTIBODY AGAINST THE GAG PROTEIN PRECURSOR p55 OF HUMAN IMMUNODEFICIENCY VIRUS
12/02/1991WO1991018980A1 Compositions and methods for identifying biologically active molecules
12/02/1991CA2084307A1 Compositions and methods for identifying biologically active molecules
12/02/1991CA2083399A1 Monoclonal antibody against the gag protein precursor p55 of human immunodeficiency virus
12/02/1991CA2043620A1 Microbially expressed portions of a monoclonal antibody block rhinovirus attachment to cell receptors
12/02/1991CA2043603A1 Hiv protease inhibitors and processes for their preparation
12/02/1991CA2043565A1 Enzyme and dna coding therefor
12/02/1991CA2043535A1 Hybridoma and production of biologically active substance
12/01/1991WO1991018925A1 Novel megakaryocyte colony stimulating factor and production thereof
12/01/1991WO1991018919A1 Purification of human interleukin-4 from a secreted escherichia coli mutant
1 ... 2748 2749 2750 2751 2752 2753 2754 2755 2756 2757 2758 2759 2760 2761 2762 2763 2764 2765 2766 2767 2768 ... 2916